Savara Inc. Files 8-K with Corporate Updates
Ticker: SVRA · Form: 8-K · Filed: Jun 7, 2024 · CIK: 1160308
| Field | Detail |
|---|---|
| Company | Savara Inc (SVRA) |
| Form Type | 8-K |
| Filed Date | Jun 7, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, filing-update, company-history
TL;DR
Savara Inc. filed an 8-K detailing corporate changes and votes, formerly Mast Therapeutics.
AI Summary
Savara Inc. filed an 8-K on June 7, 2024, reporting on events that occurred on June 6, 2024. The filing indicates changes to the company's articles of incorporation or bylaws, submission of matters to a vote of security holders, and financial statements and exhibits. The company was formerly known as Mast Therapeutics, Inc., ADVENTRX PHARMACEUTICALS INC, and BIOKEYS PHARMACEUTICALS INC.
Why It Matters
This 8-K filing signals important corporate actions and potential changes in Savara Inc.'s governance or financial structure that could impact investors.
Risk Assessment
Risk Level: low — This is a routine 8-K filing reporting on corporate actions and not indicating any immediate financial distress or significant operational shifts.
Key Players & Entities
- Savara Inc. (company) — Registrant
- Mast Therapeutics, Inc. (company) — Former Company Name
- ADVENTRX PHARMACEUTICALS INC (company) — Former Company Name
- BIOKEYS PHARMACEUTICALS INC (company) — Former Company Name
- June 6, 2024 (date) — Date of earliest event reported
- June 7, 2024 (date) — Date of report
FAQ
What specific amendments were made to Savara Inc.'s articles of incorporation or bylaws?
The filing indicates that amendments were made, but the specific details of these amendments are not provided in the provided text.
What matters were submitted to a vote of Savara Inc. security holders?
The filing states that matters were submitted to a vote, but the nature of these matters is not detailed in the provided text.
What financial statements and exhibits are included with this 8-K filing?
The filing mentions the submission of financial statements and exhibits, but their specific content is not detailed in the provided text.
When did Savara Inc. change its name from Mast Therapeutics, Inc.?
Savara Inc. changed its name from Mast Therapeutics, Inc. on March 12, 2013.
What is Savara Inc.'s Standard Industrial Classification code?
Savara Inc.'s Standard Industrial Classification code is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 741 words · 3 min read · ~2 pages · Grade level 10.5 · Accepted 2024-06-07 16:15:01
Key Financial Figures
- $0.001 — ich registered Common Stock, par value $0.001 per share SVRA The Nasdaq Global Se
Filing Documents
- d838967d8k.htm (8-K) — 42KB
- d838967dex31.htm (EX-3.1) — 5KB
- 0001193125-24-157366.txt ( ) — 173KB
- svra-20240606.xsd (EX-101.SCH) — 3KB
- svra-20240606_lab.xml (EX-101.LAB) — 18KB
- svra-20240606_pre.xml (EX-101.PRE) — 11KB
- d838967d8k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: June 7, 2024 SAVARA INC. a Delaware corporation By: /s/ Dave Lowrance Dave Lowrance Chief Financial & Administrative Officer